TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Elucid Bio; Heartflow; Abiomed; Valfix; Therox; Gore; Ablative Solutions; Miracor Medical SA; Ancora; Vectorious; Robocath; Neovasc; Cardiomech
• Equity/Stock(s)/Options (Personal) - SpectraWave; Orchestra Biomed; Applied Therapeutics; Biostar Family of Funds; Aria; Cardiac Success; Valfix; Ancora; Cagent
• Grant Support/Research Contract (Institutional) - Phillips; Vascular Dynamics; V-Wave; Biosense Webster; Abbott Vascular; Bioventrix; CSI